Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Comparison Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics With Metformin

NCT01001962 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT01001962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01001962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Comparison Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics With Metformin
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2020
Enrollment
1,054 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, type ii diabetes